The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database.

Dr Philip J. Mease shares his insights on the use of ultrasound in psoriatic arthritis diagnosis, particularly in uncovering ...

A defense expert in the case of Daniel Penny in Manhattan testified that Jordan Neely did not die from the chokehold Penny used on him in a New York City subway. The expert said he eliminated a ...

The triglyceride-glucose (TyG) index, calculated from fasting triglycerides (TG) and fasting blood glucose (FBG), and the neutrophil-to-lymphocyte ratio (NLR), an inflammation marker derived from ...

By inhibiting DPP1, brensocatib aims to reduce inflammation by blocking the activation of neutrophil serine proteases (NSPs ... resulting in rapid and near-complete depletion of blood and tissue ...

Objectives Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown aetiology that can affect almost any ...

It can lead to obstructed blood flow in the portal vein ... Recent studies have explored neutrophil extracellular traps (NETs ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Neutrophil-to-lymphocyte ratio (NLR) is a significant prognostic indicator in myeloproliferative neoplasms, correlating with ...

Mavorixafor enabled substantial reductions in G-CSF dosing while maintaining mean ANC at normal levels Phase 2 study results and new analysis confirming functionality of neutrophils in sub-study ...

BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today reported financial results ...

In cancer, NETs are expelled by activated neutrophils into the TME and blood, thereby promoting cancer spread and local and systemic immunosuppression. Reduction of NETs burden via application of ...